Stay updated with breaking news from With Merck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug company Merck is awaiting word on its emergency use authorization application for its recently announced drug molnupiravir. If approved, the anti-viral drug developed at a lab at Emory University could become the first-ever pill to treat COVID-19. The latest Georgia Today podcast examines the journey that led to this potential breakthrough and its connection to Emory.
An antiviral pill has been found to reduce the risk of hospitalisation and deaths by 50 per cent in patients diagnosed with COVID-19 during clinical trials.
An antiviral pill has been found to reduce the risk of hospitalisation and deaths by 50 per cent in patients diagnosed with COVID-19 during clinical trials.
Wochenausblick: DAX mit neuem Rekord. Fed und Inflationszahlen im Fokus! () | aktiencheck.de
Credit: Merck for Mothers The likelihood that a woman can die during childbirth is still alarmingly high in the United States. The maternity mortality rate in the U.S. is the highest among developed countries, and Black women are 2.5 times more likely to die from complications of pregnancy or childbirth than white women, according to the Centers for Disease Control and Prevention (CDC). Despite research that's found that 60 percent of all maternal deaths are preventable, a total of 658 women died of maternal causes in 2018. Get push notifications with news, features...